Received Jun 8, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | Z013655 | — |
No side effects or symptoms have been reported; a patient received CAPVAXIVE while improperly stored on 04/06/2026; This spontaneous report was received from a pharmacist and refers to 74-year-old female patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not provided. On 06-Apr-2026, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) INJ 168 mcg/ml, 0.5 mL as prophylaxis by health professional (vaccine scheme, route and anatomical location not provided; lot # Z013655 has been verified to be valid, expiration date reported and established as: 11-Aug-2027), while improperly stored. Temperature 15.3C. Time frame 720 hours 0 minutes 0 seconds. No previous temperature excursion. No side effects or symptoms have been reported. This is one of two reports from the same reporter.